Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

1.41517

SAFC

PARTECK® COAT (Polyvinyl alcohol)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JPE, USP

Fabricación farmacéutica

Sinónimos:

Parteck® Polyvinyl alcohol, PVA, PVOH

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula lineal:
(C2H4O)n
Número de CAS:
9002-89-5
Número MDL:
MFCD00081922
Código UNSPSC:
13111042
En este momento no podemos mostrarle ni los precios ni la disponibilidad

Agency

ChP
JPE
Ph. Eur.
USP

Nivel de calidad

500

Línea del producto

EMPROVE® ESSENTIAL

Formulario

fine powder

tamaño de partícula

180-260 μm (d50)

mp

160-240 °C

aplicaciones

pharmaceutical
solid formulation

Condiciones de envío

ambient

temp. de almacenamiento

15-25°C

InChI

1S/C2H4O/c1-2-3/h2-3H,1H2

Clave InChI

IMROMDMJAWUWLK-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Aplicación

Parteck® COAT excipient is a particle-engineered polyvinyl alcohol (PVA) with a unique structure specifically designed for immediate release film coating application. Due to its optimized particle size, it helps to reduce dissolving times when preparing the coating solution, thus increasing process efficiency. Parteck® COAT excipient can be combined with a variety of supporting excipients such as plasticizers, anti-tacking agents and pigments – all available in our portfolio – to give you full flexibility in designing just the right coating for your need, and in the right timeframe. It is also very well-suited for coating ODT formulations using the Parteck® ODT orally disintegrating excipient system.

Características y beneficios

  • Excellent surface finishing - improve the appearance of your formulation
  • Rapid preparation of coating liquids even at room temperature
  • Low viscosity of coating liquids at high polymer concentration – enables reduced process times and enhanced efficiency
  • Stable moisture and oxygen barrier - effective protection of moisture-sensitive APIs

Información legal

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

también adquirido normalmente con este producto

Referencia del producto
Descripción
Precios

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 1

¿Qué es el programa Emprove®?

El programa Emprove® es un sistema que proporciona documentación completa y exhaustiva de nuestros filtros y componentes de un solo uso, materias primas farmacéuticas y materiales de partida.

Material Qualification Dossier

Gratuito, iniciar sesión para descargar

Quality Management Dossier (Open Access)

Gratuito, iniciar sesión para descargar

Quality Management Dossier (Open Access)

Gratuito, iniciar sesión para descargar

Operational Excellence Dossier

Disponible mediante suscripción o mediante pago de una tarifa.

Operational Excellence Dossier

Disponible mediante suscripción o mediante pago de una tarifa.

Operational Excellence Dossier

Disponible mediante suscripción o mediante pago de una tarifa.

Más información sobre las ventajas que le puede proporcionar una suscripción al programa Emprove®
¿Por qué no están disponibles estos documentos?
Los expedientes Emprove® contienen información destinada a respaldar el proceso de registro y las actividades de evaluación del riesgo de los productores farmacéuticos y contienen información confidencial. contacte con nosotros si desea tener acceso.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Artículos

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Contenido relacionado

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Questions

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico